Vancomycin is an essential antibiotic for treating methicillin-resistant Staphylococcus Aureus (MRSA) infections. Vancomycin requires close monitoring because of its potential to damage the kidney.1 Evidence now supports the use of a new parameter, area-under-the-curve (AUC), to monitor vancomycin dosing and recently has become the standard-of-care.2,3,4 The preferred method for estimating AUC is with sophisticated, computer software using a Bayesian analysis. The expense of commercially available programs may be difficult to justify for hospitals with limited budgets, especially smaller hospitals that infrequently administer vancomycin to patients.
© 2021 Staci Hemmer
Hemmer, Staci, "Readiness for AUC-Dosing of Vancomycin in Montana Hospitals" (2021). University Grant Program Reports. 65.